AN2 Therapeutics
Clinical-stage biopharmaceutical company developing novel therapeutics for serious and life-threatening infectious diseases, including nontuberculous mycobacterial (NTM) lung disease.
Location
Menlo Park, California, USA
Founded
2018
Investors
1
Categories
biotech, infectious-disease, antibiotics, therapeutics
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Adjuvant Capital | Washington, DC, USA | biotech-focused | seedseries-a+3 | 16 |